| Trial ID: | L0236 |
| Source ID: | NCT01308242
|
| Associated Drug: |
Sevelamer Carbonate
|
| Title: |
Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Sevelamer Carbonate
|
| Outcome Measures: |
Primary: Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease, Determine if phosphate reduction through the use of non-calcium based phosphate binders will decrease serum FGF23 levels, March 2011-June 2012 |
|
| Sponsor/Collaborators: |
Sponsor: Milton S. Hershey Medical Center | Collaborators: Genzyme, a Sanofi Company
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
EARLY_PHASE1
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SCREENING
|
| Start Date: |
2011-03
|
| Completion Date: |
2014-02-27
|
| Results First Posted: |
|
| Last Update Posted: |
2018-05-02
|
| Locations: |
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01308242
|
